Service de médecine gériatrique, Hospices Civils de Lyon, Groupement Hospitalier Sud, 69495 Pierre-Bénite, France.
Research on Healthcare professionals and Performance (RESHAPE, inserm U1290), université Claude Bernard Lyon1, Lyon, France.
Age Ageing. 2022 Jan 6;51(1). doi: 10.1093/ageing/afab126.
The Hospital Frailty Risk Score (HFRS) has made it possible internationally to identify subgroups of patients with characteristics of frailty from routinely collected hospital data.
To externally validate the HFRS in France.
A retrospective analysis of the French medical information database.
743 hospitals in Metropolitan France.
All patients aged 75 years or older hospitalised as an emergency in 2017 (n = 1,042,234).
The HFRS was calculated for each patient based on the index stay and hospitalisations over the preceding 2 years. Main outcome measures were 30-day in-patient mortality, length of stay (LOS) >10 days and 30-day readmissions. Mixed logistic regression models were used to investigate the association between outcomes and HFRS score.
Patients with high HFRS risk were associated with increased risk of mortality and prolonged LOS (adjusted odds ratio [aOR] = 1.38 [1.35-1.42] and 3.27 [3.22-3.32], c-statistics = 0.676 and 0.684, respectively), while it appeared less predictive of readmissions (aOR = 1.00 [0.98-1.02], c-statistic = 0.600). Model calibration was excellent. Restricting the score to data prior to index admission reduced discrimination of HFRS substantially.
HFRS can be used in France to determine risks of 30-day in-patient mortality and prolonged LOS, but not 30-day readmissions. Trial registration: Reference ID on clinicaltrials.gov: ID: NCT03905629.
医院衰弱风险评分(HFRS)使得从常规收集的医院数据中识别具有衰弱特征的患者亚组成为可能。
在法国对 HFRS 进行外部验证。
对法国医疗信息数据库的回顾性分析。
法国大都市 743 家医院。
2017 年因急症住院的所有 75 岁及以上患者(n=1042234)。
根据索引住院和前 2 年的住院情况,为每位患者计算 HFRS。主要结局指标为 30 天住院死亡率、住院时间延长(LOS)>10 天和 30 天再入院率。采用混合逻辑回归模型研究结局与 HFRS 评分之间的关系。
HFRS 风险高的患者死亡风险和 LOS 延长的风险增加(校正比值比[aOR]分别为 1.38 [1.35-1.42]和 3.27 [3.22-3.32],C 统计量分别为 0.676 和 0.684),而对再入院的预测作用较小(aOR=1.00 [0.98-1.02],C 统计量为 0.600)。模型校准效果良好。将评分限制在索引入院前的数据会大大降低 HFRS 的区分度。
HFRS 可用于法国确定 30 天住院死亡率和 LOS 延长的风险,但不能用于 30 天再入院率。
clinicaltrials.gov 参考 ID:ID:NCT03905629。